Expert Rev Endocrinol Metab. 2012;7(4):433-443. It is not recommended to stop an already initiated insulin infusion, but rather to introduce dextrose infusion with a 'two-bag system' if the blood ...

Fluid management. Fluid resuscitation is the first step in DKA therapy. 3 The total fluid deficit is estimated to be 3.0 to 6.0 L in DKA. 5 Fluid is replaced as a crystalloid bolus to improve GFR ...

Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can't produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can’t produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by health care professionals in real time, via a sensor under the skin, and they ...

Serum bicarbonate level also did not appear to affect the accuracy of real-time continuous glucose monitoring (rtCGM) in pediatric diabetic ketoacidosis (DKA). The use of real-time continuous glucose ...

Patients with SGLT2 inhibitor-associated diabetic ketoacidosis (DKA) received significantly lower doses of insulin in the first 24 hours of treatment compared with patients with type 1 diabetes DKA, ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes hospitalized with DKA recurrence have a higher risk for mortality. Providers should closely ...

Expert Rev Endocrinol Metab. 2012;7(4):433-443. The insulin rate does not typically change during the use of the two-bag system. In unusual circumstances with hypoglycemia and maximized dextrose ...

To develop DKA, the patient must experience a relative insulin deficiency 4 (very little circulating insulin) in the setting of increased counter-regulatory hormone concentrations. This relative lack ...